Anavex Life Sciences Corp. (AVXL) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Anavex Life Sciences Corp..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.517 Good morning, everyone, and welcome to the Anovex Life Sciences Fiscal 2026 00:00:05.517 -- 00:00:10.102 First Quarter Conference Call. My name is Clint Tomlinson, and I will be your host for 00:00:10.102 -- 00:00:14.707 today's call. At this time, all participants are in a listen-only mode. 00:00:14.707 -- 00:00:18.131 Later, we will conduct a question-and-answer session, and during this session, if you 00:00:18.131 -- 00:00:24.396 would like to ask a question, please use the Q&A box or raise your hand. 00:00:24.759 -- 00:00:29.761 Please note this conference is being recorded, and the call will be available on Anavex's 00:00:29.761 -- 00:00:32.945 website at www.anavex.com. 00:00:34.156 -- 00:00:38.471 With us today is Dr. Christopher Missling, President and Chief Executive Officer, and 00:00:38.471 -- 00:00:42.067 Sondra Burnish, Principal Financial Officer. 00:00:42.067 -- 00:00:45.592 Before we begin, please note that during this conference call, the company will make 00:00:45.592 -- 00:00:48.256 some projections and forward-looking statements. 00:00:48.256 -- 00:00:53.103 These statements are only predictions based on current information and expectations and 00:00:53.103 -- 00:00:55.607 involve a number of risks and uncertainties. 00:00:55.607 -- 00:00:59.573 We encourage you to review the company's filings with the SEC, and this includes, without 00:00:59.573 -- 00:01:04.601 limitation, the company's forms 10-K and 10-Q, which identify the specific 00:01:04.601 -- 00:01:09.648 factors that may cause actual results or events to differ materially from those described 00:01:09.648 -- 00:01:11.986 in these forward-looking statements. 00:01:11.986 -- 00:01:16.491 These factors may include without limitation risks inherent in the ...